PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Description

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

Conditions

NSCLC Stage II, NSCLC, Stage III

Talk to us

Study Overview

On this page

Study Details

Study overview

This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study

Condition
NSCLC Stage II
Intervention / Treatment

-

Contacts and Locations

Salt Lake City

Huntsman Cancer Institute, Salt Lake City, Utah, United States, 84112

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Ages 18 and older at time of diagnosis
  • * Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
  • * Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
  • * Patient able to follow direction and complete questionnaires in English or Spanish
  • * Patient agrees to complete the PERCC intervention
  • * Morbidly obese (BMI \>40 kg/m2 ) or anorexic (BMI \<17.5 kg/m2 )
  • * Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance
  • * Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)
  • * Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Utah,

Study Record Dates

2030-05